Vital Chemtech Limited (NSE:VITAL)
India · Delayed Price · Currency is INR 52.85
-1.07 (-1.98%)
Jul 14, 2026, 11:14 AM IST
Vital Chemtech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,264 | 1,339 | 982.74 | 1,167 | 576.15 |
Other Revenue | - | - | - | 0 | -0 |
| 1,264 | 1,339 | 982.74 | 1,167 | 576.15 | |
Revenue Growth (YoY) | -5.57% | 36.26% | -15.82% | 102.63% | 21.54% |
Cost of Revenue | 970.64 | 1,065 | 759.46 | 859.89 | 391.87 |
Gross Profit | 293.78 | 274.02 | 223.28 | 307.55 | 184.28 |
Selling, General & Admin | 70.98 | 61.29 | 36.86 | 29.36 | 19.12 |
Other Operating Expenses | 122.44 | 98.82 | 187.09 | 128.63 | 49.21 |
Operating Expenses | 253.36 | 209.85 | 250.29 | 181.17 | 75.29 |
Operating Income | 40.42 | 64.16 | -27.01 | 126.38 | 108.99 |
Interest Expense | -31.21 | -19.41 | -6.78 | -5.7 | -1.69 |
Interest & Investment Income | - | 17.41 | 23.46 | 7.28 | 0.53 |
Currency Exchange Gain (Loss) | - | 2.26 | 7.41 | -7.48 | 1.31 |
Other Non Operating Income (Expenses) | 8.64 | -2.34 | -5.69 | -5.53 | -3.15 |
EBT Excluding Unusual Items | 17.85 | 62.09 | -8.61 | 114.95 | 105.98 |
Gain (Loss) on Sale of Investments | 3.02 | - | 4.95 | - | - |
Gain (Loss) on Sale of Assets | - | - | 0.13 | -0.1 | - |
Pretax Income | 20.87 | 62.09 | -3.53 | 114.85 | 105.98 |
Income Tax Expense | 10.6 | 21.53 | 9.5 | 34.33 | 27 |
Net Income | 10.27 | 40.56 | -13.02 | 80.51 | 78.98 |
Net Income to Common | 10.27 | 40.56 | -13.02 | 80.51 | 78.98 |
Net Income Growth | -74.68% | - | - | 1.94% | 168.85% |
Shares Outstanding (Basic) | 23 | 24 | 24 | 18 | 7 |
Shares Outstanding (Diluted) | 24 | 24 | 24 | 18 | 7 |
Shares Change (YoY) | -0.49% | 0.20% | 33.87% | 166.18% | -39.99% |
EPS (Basic) | 0.44 | 1.69 | -0.54 | 4.50 | 11.75 |
EPS (Diluted) | 0.43 | 1.69 | -0.54 | 4.50 | 11.75 |
EPS Growth | -74.56% | - | - | -61.70% | 348.47% |
Free Cash Flow | -186.05 | -396.23 | -68.25 | -178.22 | -219.24 |
Free Cash Flow Per Share | -7.79 | -16.51 | -2.85 | -9.96 | -32.62 |
Dividend Per Share | - | - | 0.500 | 0.500 | - |
Gross Margin | 23.23% | 20.46% | 22.72% | 26.34% | 31.99% |
Operating Margin | 3.20% | 4.79% | -2.75% | 10.82% | 18.92% |
Profit Margin | 0.81% | 3.03% | -1.32% | 6.90% | 13.71% |
Free Cash Flow Margin | -14.71% | -29.59% | -6.94% | -15.27% | -38.05% |
EBITDA | 100.36 | 113.91 | -0.68 | 149.55 | 115.95 |
EBITDA Margin | 7.94% | 8.51% | -0.07% | 12.81% | 20.13% |
D&A For EBITDA | 59.94 | 49.75 | 26.33 | 23.18 | 6.96 |
EBIT | 40.42 | 64.16 | -27.01 | 126.38 | 108.99 |
EBIT Margin | 3.20% | 4.79% | -2.75% | 10.82% | 18.92% |
Effective Tax Rate | 50.80% | 34.67% | - | 29.89% | 25.48% |
Revenue as Reported | 1,276 | 1,360 | 1,016 | 1,169 | 578.7 |
Advertising Expenses | - | 0.83 | - | 0.92 | 5.93 |